BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 27562387)

  • 1. GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma.
    Canpolat T; Ersöz C; Uğuz A; Vardar MA; Altintaş A
    Turk Patoloji Derg; 2016; 32(3):141-7. PubMed ID: 27562387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
    Xiong Y; Xiong YY; Zhou YF
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
    Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
    Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma.
    Ashton-Sager A; Paulino AF; Afify AM
    Appl Immunohistochem Mol Morphol; 2006 Jun; 14(2):187-92. PubMed ID: 16785788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
    Xiong Y; Xiong YY; Zhou YF
    Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of ERK1/2 and p-AKT in normal endometrium, endometrial hyperplasia, and early and advanced stage endometrioid endometrial adenocancer and their prognostic significance in malignant group.
    Gungorduk K; Ertas IE; Sahbaz A; Ozvural S; Sarica Y; Ozdemir A; Sayhan S; Gokcu M; Yilmaz B; Sanci M; Inan S; Harma M; Yildirim Y
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():147-52. PubMed ID: 24965996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium.
    Erkanli S; Kayaselcuk F; Kuscu E; Bagis T; Bolat F; Haberal A; Demirhan B
    Int J Gynecol Cancer; 2006; 16(3):1412-8. PubMed ID: 16803539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma.
    Assaf MI; Abd El-Aal W; Mohamed SS; Yassen NN; Mohamed EA
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2291-2297. PubMed ID: 30139240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis.
    Ruhul Quddus M; Latkovich P; Castellani WJ; James Sung C; Steinhoff MM; Briggs RC; Miranda RN
    Arch Pathol Lab Med; 2002 Apr; 126(4):459-63. PubMed ID: 11900573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UbcH10 expression in benign, hyperplastic, and malignant endometrial curetted materials: a tissue microarray study.
    Kefeli M; Yildiz L; Celik H; Tosun M; Karagoz F
    Int J Surg Pathol; 2012 Aug; 20(4):360-6. PubMed ID: 22415060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between C-kit expression and mean platelet volume in benign, preneoplastic and neoplastic endometrium.
    Sehitoglu I; Bedir R; Ural UM; Gucer H; Yurdakul C; Cure MC; Cure E; Yuce S; Sahin FK
    Asian Pac J Cancer Prev; 2015; 16(4):1495-9. PubMed ID: 25743820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
    Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
    J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maspin expression, subcellular localization and clinicopathological correlation in endometrial hyperplasia and endometrial adenocarcinoma.
    Blandamura S; Alessandrini L; Saccardi C; Giacomelli L; Fabris A; Borghero A; Litta P
    Histol Histopathol; 2014 Jun; 29(6):777-83. PubMed ID: 24346847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of skp2 correlates with poor prognosis in endometrial endometrioid adenocarcinoma.
    Kamata Y; Watanabe J; Nishimura Y; Arai T; Kawaguchi M; Hattori M; Obokata A; Kuramoto H
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):591-6. PubMed ID: 16080017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PINCH protein expression in normal endometrium, atypical endometrial hyperplasia and endometrioid endometrial carcinoma.
    Zhang HZ; Li XH; Zhang X; Zhang ZY; Meng YL; Xu SW; Zheng Y; Zhu ZL; Cui DS; Huang LX; Yan BY; Sun XF
    Chemotherapy; 2010; 56(4):291-7. PubMed ID: 20714146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.
    Nishimura Y; Watanabe J; Jobo T; Kato N; Fujisawa T; Kamata Y; Kuramoto H
    Anticancer Res; 2004; 24(4):2185-91. PubMed ID: 15330159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
    Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
    Ozuysal S; Oztürk H; Bilgin T; Filiz G
    Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.